Overview
- The Royal House and Oslo University Hospital reported a clear deterioration in recent tests for the 52-year-old, who was diagnosed with pulmonary fibrosis in 2018.
- Professor Are Martin Holm said physicians are approaching the point where a transplant may be necessary and are preparing to enable the procedure when appropriate.
- The palace said no decision has been made on when she might be added to the transplant waiting list.
- Mette-Marit told NRK the disease has progressed faster than she and her doctors anticipated, while the palace will adjust her official program so she can continue duties as her health allows.
- Medical officials described transplantation as a last-resort option with significant risks and dependent on clinical suitability and donor matching, as public attention on the royal family intensifies with her son’s trial set for early 2026.